Clinical Trials | June 18, 2026
Suven reports positive Phase 2b results for Ropanicant in major depressive disorder
Suven has already begun planning a global Phase 3 registrational program for MDD based on the results
Suven has already begun planning a global Phase 3 registrational program for MDD based on the results
Veteran healthcare executive to drive international growth, strategic partnerships, and global commercialization of the company's molecular diagnostics portfolio
Mahler brings more than 20 years of leadership experience spanning cell therapy, biopharmaceutical development, manufacturing, and global business management
From a $10 billion bioeconomy to over $190 billion, indigenous CAR-T therapy, and a booming startup ecosystem highlight 12 years of transformation in India’s science and technology landscape
Exclusive partnership introduces globally benchmarked stem cell processing platform aimed at improving stem cell recovery, quality, and long-term therapeutic potential
Both nations deepen cooperation in health innovation, AI-driven healthcare, biomedical research, data sharing, and life sciences to accelerate next-generation healthcare solutions
Supreme Court grants PULSUS Ameenpur project ITeS Park and SEZ status, strengthening Telangana's position in AI, healthcare technology, and digital services
Company experts to participate in eight sessions covering AI-powered clinical development, regulatory innovation, oncology research, and patient engagement
Pharmaceutical R&D veteran brings over 20 years of expertise in formulation development, ANDA filings, and regulated-market product innovation to strengthen MSN Laboratories’ global growth ambitions
The validation confirms the submission is complete, clearing the way for the EMA’s centralized review process to formally evaluate the therapy
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
